Tag: licensing
-
Spin-Off Creates Enzyme to Prevent Celiac Disease
A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease.
-
Cell Biotech Gains Organoid Technology
A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs.
-
New Type of Antibiotic Set for Early Trial
A clinical trial is set to test a type of drug that its developers say is designed to treat infections from bacteria resistant to earlier antibiotics.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.
-
Engineered T-Cells Tested on Metastatic Cancer
An individual with lung cancer tumors that spread from the colon had the tumors reduced in size after a single treatment of modified cancer-killing immune system cells.
-
Start-Up Developing Nanotech Bone Repairs
An enterprise formed earlier this year is licensing an engineered bone tissue repair technology that mixes ultrafine diamond particles with biocompatible polymers.
-
LEDs Shown to Reduce Alzheimer’s Brain Plaques
Pulsating LED lights were shown in lab mice to reduce amyloid-beta plaque deposits associated with Alzheimer’s disease on brain cells, with the lead researchers starting a company to commercialize the technology.
-
Start-Up Reprogramming Stem Cells to Treat Heart Failure
A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure.
-
Biotech to Earn Up to $1 Billion from Synthetic Peptides
A biotechnology enterprise designing synthetic peptides to treat a range of diseases could gain up to $1 billion or more in a licensing deal with the pharmaceutical company AstraZeneca.
-
Company Launches to Discover Gut-Brain Therapies
A California Institute of Technology biologist is starting a new enterprise to discover treatments for neurological disorders through pathways originating in the gut.